Health initiatives

Nightingale’s health data platform offers novel scientific opportunities for large-scale health initiatives. Comprehensive health results can be given to both scientists and participants to advance research and personal health.

Analysing half a million samples from UK Biobank

Nightingale is analysing the biomarker profiles of 500,000 blood samples from the UK Biobank, the world's largest health database. The comprehensive metabolic biomarker profiles will be analysed in 30 months to facilitate global medical research a wealth of scientific applications.

Read more →
GLOBAL COLLABORATIONS
Press release

Nightingale and Estonian Biobank Agree Strategic Collaboration Aiming to Work Towards Estonian Biobank’s Nationwide Early Disease Prevention in Estonia

February 4, 2021
Collaboration

Nightingale and Imperial College London to investigate new indicators of diabetes in the South Asian population

November 4, 2019
Collaboration

Nightingale collaborates with National University of Singapore to realise the prevention of chronic diseases in South East Asia

May 8, 2019
Collaboration

Nightingale to analyse the world’s largest blood-based prospective cohort study in Latin America

September 4, 2018
Collaboration

Nightingale and THL Biobank to analyze 40,000 blood samples

March 12, 2018
Collaboration

Pioneering China Kadoorie Biobank study uses Nightingale technology

February 14, 2018
World-leading publications
For individuals
Blood test and app
FAQ
Buy
Sign in
For business
Nightingale for business
Health initiatives
For research
Blood Biomarker Analysis
Biomarkers
Publications
About us
Company
Technology
News
Careers
Contact
Get our newsletter
Interested in getting the latest news about Nightingale? Subscribe to our newsletter.
Nightingale Health Oy
Mannerheimintie 164A, 00300 Helsinki, Finland
Contact →
© 2020 Nightingale HealthTerms and policies